IOVA
#2080
Iovance Biotherapeutics, Inc. - Common Stock
3.9 3 USD
-0.03%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.72%
Monthly Change
-4.61%
6 month change
+65.82%
Year Change
+107.94%
Previous Close
4.0 4
Open
3.9 2
Low
3.9 1
High
3.9 7
Volume
2 149
Financials
- Market Capitalization 1.75 B
- Employee 975
- Founded 2007
- CEO N/A
- Website www.iovance.com
- Headquarter Delaware, United States
- FIGI BBG000FTLBV7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.5
Price to sales ratio
0
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2061 |  ZYME Zymeworks Inc. - Common Stock | 24.68 USD | -1.04% | -7.63% | +7.21% | +39.12% | 1.80 B USD | ||
| 2075 |  AAPG Ascentage Pharma Group International - American Depository Shar | 19.23 USD | -1.99% | +2.94% | +7.01% | -23.08% | 1.79 B USD | ||
| 2083 |  ZBIO Zenas BioPharma, Inc. - Common Stock | 28.80 USD | +3.30% | +4.05% | +39.74% | +8.84% | 1.82 B USD | ||
| 2084 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.35 USD | +1.52% | -12.76% | +1.52% | -36.91% | 1.78 B USD |
Frequently asked questions about Iovance Biotherapeutics, Inc. - Common Stock
What is the Iovance Biotherapeutics, Inc. - Common Stock stock price today?
The current price of Iovance Biotherapeutics, Inc. - Common Stock (IOVA) is 3.93. Over the past 24 hours, the stock has changed by -2.72%. Follow the IOVA chart for real-time price dynamics.
What is the stock ticker of Iovance Biotherapeutics, Inc. - Common Stock?
Iovance Biotherapeutics, Inc. - Common Stock trades under the ticker IOVA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Iovance Biotherapeutics, Inc. - Common Stock stock going up?
IOVA has changed by -9.66% over the last week, -4.61% over the last month, and +107.94% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Iovance Biotherapeutics, Inc. - Common Stock net income for the last quarter?
Iovance Biotherapeutics, Inc. - Common Stock reported net income of -79.05 M for the last quarter. The previous quarter showed -71.9 M, which means net income changed by -9.93%.
How many employees does Iovance Biotherapeutics, Inc. - Common Stock have?
As of the latest available data, Iovance Biotherapeutics, Inc. - Common Stock has 975 employees. Workforce size can provide additional context about the company's scale and operations.
What is Iovance Biotherapeutics, Inc. - Common Stock EBITDA?
Iovance Biotherapeutics, Inc. - Common Stock EBITDA is -78.22 M, and its EBITDA margin is -109.51%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Iovance Biotherapeutics, Inc. - Common Stock stock?
You can buy Iovance Biotherapeutics, Inc. - Common Stock (IOVA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Iovance Biotherapeutics, Inc. - Common Stock stock?
Investing in Iovance Biotherapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IOVA chart and related analysis on metatrader.com as part of your research.